Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness (APEX-Return)

NCT07280247 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.

NCT NCT07280247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07280247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness (APEX-Return)
Lead sponsor
Angiodynamics, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
March 30, 2026
Completion date
December 31, 2026
Enrollment
39 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism acute